Although the majority of authors in the literature lean towards pro-tumorigenic effects of NLRP3 inflammasome, there are examples of remission symptoms and less body loss in a CRC experimental mice model upon NLRP3 activation [128]. Here, NLRP3 is linked to colorectal carcinoma.